Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer

British Journal of Surgery

Volumn 94, Issue 5, 2007, Pages 578-584

  Thompson, A M ^a   Rapson, T ^b   Gilbert, F J ^c   Park, K G M ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Epidemiology and Statistics Group   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SCOTLAND; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34248343885     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5729     Document Type: Article

References (36)

1. Thompson AM. Oesophageal and stomach cancers. In Cancer Scenarios. An Aid to Planning Cancer Services in Scotland in the Next Decade. Scottish Executive: Edinburgh, 2001; 32-47.
2. Goodney PP, Siewers AE, Stukel TA, Lucas FL, Wennberg DE, Birkmeyer JD. Is surgery getting safer? National trends in operative mortality. J Am Coll Surg 2002; 195: 219-227.
3. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
4. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al., MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
5. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
6. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD et al. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 2003; 57: 120-127.
7. Thompson AM, Rapson T, Gilbert FJ, Park KGM. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc 2004; 18: 1257-1262.
8. Herskovic A, Martz K, al-Sharraf M, Leichman L, Brindle J, Vaitkevicius V et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-1598.
9. Munro AJ. Oesophageal cancer: a view over overviews. Lancet 2004; 364: 566-568.
10. Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg 2005; 92: 389-402.
11. Pye JK, Crumplin MK, Charles J, Kerwat R, Foster ME, Biffin A, on behalf of hospital clinicians in Wales. One-year survey of carcinoma of the oesophagus and stomach in Wales. Br J Surg 2001; 88: 278-285.
12. Bachmann MO, Alderson D, Edwards D, Wotton S, Bedford C, Peters TJ et al. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br J Surg 2002; 89: 914-922.
13. Dehn TC. Guidelines for treatment of upper gastrointestinal cancer. Lancet 2002; 360: 1101-1102.
14. Gillison EW, Powell J, McConkey CC, Spychal RT. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg 2002; 89: 344-348.
15. McCulloch P, Ward J, Tekkis PP, ASCOT group of surgeons, British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003; 327: 1192-1197.
16. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137.
17. Damhuis RA, Meurs CJ, Dijkhuis CM, Stassen LP, Wiggers T. Hospital volume and post-operative mortality after resection for gastric cancer. Eur J Surg Oncol 2002; 28: 401-405.
18. Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91: 943-947.
19. Swisher SG, Deford L, Merriman KW, Walsh GL, Smythe R, Vaporicyan A et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119: 1126-1132.
20. Scottish Executive. Department of Health. NHS MEL (1999); 10; Introduction of Managed Clinical Networks Within the NHS in Scotland. http://www.mcn.scot.nhs.uk/pdf/ mel199910.pdf (accessed 5 February 2007).
21. NHS Executive. Guidance on Commissioning Cancer Services: Improving Outcomes in Upper Gastro-intestinal Cancers. The Research Evidence. Health Services Directorate, NHS Executive: London, 2001.
22. Kendrick S, Clarke J. The Scottish Record Linkage System. Health Bull (Edinb) 1993; 51: 72-79.
23. Hakulinen T. Cancer survival corrected for heterogeneity inpatient withdrawal. Biometrics 1982; 38: 933-942.
24. Dickman PW, Sloggett A, Hills M, Halulinen T. Regression models for relative survival. Stat Med 2004; 23: 51-64.
25. Liu JF, Wang QZ, Hou J. Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China. Br J Surg 2004; 91: 90-98.
26. Association of Upper Gastrointestinal Cancer Surgeons (AUGIS). Second Oesophago-gastric Audit Report 2005. http://www.augis.org (accessed 5 February 2007).
27. Lehnert T, Rudek B, Kienle P, Buhl K, Herfarth C. Impact of diagnostic laparoscopy on the management of gastric cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma. Br J Surg 2002; 89: 471-475.
28. Clements DM, Bowrey DJ, Havard TJ. The role of staging investigations for oesophago-gastric carcinoma. Eur J Surg Oncol 2004; 30: 309-312.
29. Sauvanet A, Mariette C, Thomas P, Lozac'h P, Segol P, Tiret E et al. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg 2005; 201: 253-262.
30. Sasako M, Sano T, Sairenji M, Arai K, Kinoshita T, Yamamoto S et al. Left thoracoabdominal approach (LT) compared with abdominal and transhiatal approach (AT) for cardia or sub-cardia cancer. Results of a surgical randomized controlled trial (JCOG9502). J Clin Oncol 2004; 22(Suppl): 4000 (Abstract).
31. Hayes N, Ng EK, Raimes SA, Crofts TJ, Woods SD, Griffin SM et al. Total gastrectomy with extended lymphadenectomy for 'curable' stomach cancer: experience in a non-Japanese Asian center. J Am Coll Surg 1999; 188: 27-32.
32. Mulligan ED, Dunne B, Griffin M, Keeling N, Reynolds JV. Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit. Eur J Surg Oncol 2004; 30: 313-317.
33. McArdle CS, McKee RF, Finlay IG, Wotherspoon H, Hole DJ. Improvement in survival following surgery for colorectal cancer. Br J Surg 2005; 92: 1008-1013.
34. Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 1999; 318: 1099-1103.
35. Soljak M. Volume of procedures and outcome of treatment. BMJ 2002; 325: 787-788.
36. Urbach DR, Baxter NN. Does it matter what a hospital is 'high volume' for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data. BMJ 2004; 328: 737-740.